- Home
- ALDX vs DBI Comparison
ALDX vs DBI Comparison
Compare ALDX & DBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALDX
- DBI
- Stock Information
- Founded
- ALDX 2004
- DBI 1991
- Country
- ALDX United States
- DBI United States
- Employees
- ALDX N/A
- DBI N/A
- Industry
- ALDX Biotechnology: Pharmaceutical Preparations
- DBI Clothing/Shoe/Accessory Stores
- Sector
- ALDX Health Care
- DBI Consumer Discretionary
- Exchange
- ALDX Nasdaq
- DBI Nasdaq
- Market Cap
- ALDX 133.7M
- DBI 137.2M
- IPO Year
- ALDX 2014
- DBI 1991
- Fundamental
- Price
- ALDX $2.24
- DBI $3.24
- Analyst Decision
- ALDX Strong Buy
- DBI Hold
- Analyst Count
- ALDX 2
- DBI 2
- Target Price
- ALDX $9.50
- DBI $4.75
- AVG Volume (30 Days)
- ALDX 1.5M
- DBI 1.6M
- Earning Date
- ALDX 05-20-2025
- DBI 06-03-2025
- Dividend Yield
- ALDX N/A
- DBI 6.01%
- EPS Growth
- ALDX N/A
- DBI N/A
- EPS
- ALDX N/A
- DBI N/A
- Revenue
- ALDX N/A
- DBI $3,009,262,000.00
- Revenue This Year
- ALDX N/A
- DBI $2.22
- Revenue Next Year
- ALDX N/A
- DBI $2.18
- P/E Ratio
- ALDX N/A
- DBI N/A
- Revenue Growth
- ALDX N/A
- DBI N/A
- 52 Week Low
- ALDX $1.14
- DBI $2.44
- 52 Week High
- ALDX $7.20
- DBI $11.06
- Technical
- Relative Strength Index (RSI)
- ALDX 36.53
- DBI 56.56
- Support Level
- ALDX $1.90
- DBI $2.78
- Resistance Level
- ALDX $2.89
- DBI $3.38
- Average True Range (ATR)
- ALDX 0.22
- DBI 0.17
- MACD
- ALDX 0.09
- DBI 0.10
- Stochastic Oscillator
- ALDX 33.46
- DBI 88.24
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.